• Òscar Miró, Julio Núñez, Joan Carles Trullàs, Pedro Lopez-Ayala, Lluís Llauger, Aitor Alquézar-Arbé, Gema Miñana, Anna Mollar, Rafael de la Espriella, Miguel Lorenzo, Javier Jacob, Begoña Espinosa, Vanesa Garcés-Horna, Alfons Aguirre, María José Fortuny, Gemma Martínez-Nadal, Víctor Gil, Christian Mueller, Pere Llorens, ICA-SEMES, INCLIVA, and ALCALOTIC research groups.
• Emergency Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain; The GREAT network, Rome, Italy.
• Eur. J. Intern. Med. 2024 Sep 1; 127: 126133126-133.

ObjectiveTo investigate the association of the addition of thiazide diuretic on top of loop diuretic and standard of care with short-term outcomes of patients discharged after surviving an acute heart failure (AHF) episode.MethodsThis is a secondary analysis of 14,403 patients from three independent cohorts representing the main departments involved in AHF treatment for whom treatment at discharge was recorded and included loop diuretics. Patients were divided according to whether treatment included or not thiazide diuretics. Short-term outcomes consisted of 30-day all-cause mortality, hospitalization (with a separate analysis for hospitalization due to AHF or to other causes) and the combination of death and hospitalization. The association between thiazide diuretics on short-term outcomes was explored by Cox regression and expressed as hazard ratios (HR) with 95 % confidence intervals, which were adjusted for 18 patient-related variables and 9 additional drugs (aside from loop and thiazide diuretics) prescribed at discharge.ResultsThe median age was 81 (interquartile range=73-86) years, 53 % were women, and patients were mainly discharged from the cardiology (42 %), internal medicine or geriatric department (29 %) and emergency department (19 %). There were 1,367 patients (9.5 %) discharged with thiazide and loop diuretics, while the rest (13,036; 90.5 %) were discharged with only loop diuretics on top of the remaining standard of care treatments. The combination of thiazide and loop diuretics showed a neutral effect on all outcomes: death (adjusted HR 1.149, 0.850-1.552), hospitalization (0.898, 0.770-1.048; hospitalization due to AHF 0.799, 0.599-1.065; hospitalization due to other causes 1.136, 0.756-1.708) and combined event (0.934, 0.811-1.076).ConclusionThe combination of thiazide and loop diuretics was not associated with changes in risk of death, hospitalization or a combination of both.Copyright © 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

28 keywords...

hide…